If you have type 1 or type 2 diabetes, your doctor might prescribe Toujeo. It’s a prescription diabetes medication used in adults and some children. To learn more about diabetes and how Toujeo is used ...

If you have diabetes, your doctor may suggest Toujeo (insulin glargine) as a treatment option. This article describes the dosages of Toujeo, as well as its form, strength, and how to take it. It’s ...

Toujeo is an injectable insulin medication for the treatment of diabetes (type 1 or type 2) in people who are 6 years old and older. It is a long-acting form of insulin, which allows it to last for a ...

Toujeo (insulin glargine) is a brand-name drug that’s prescribed for type 1 or type 2 diabetes. The medication is available in these forms: Toujeo SoloStar insulin pen and Toujeo Max SoloStar insulin ...

Sanofi announced that the Food and Drug Administration (FDA) has approved Toujeo (insulin glargine 300 Units/mL) Max SoloStar, a long-acting insulin pen that holds 900 Units of Toujeo and provides up ...

The FDA on February 25, 2015, approved the basal insulin Toujeo, which Sanofi sees as a successor to Lantus to treat patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM). Toujeo, insulin ...

Two new insulins marketed by Sanofi offer improved options for patients: Toujeo is longer acting than its predecessor, Lantus. Afrezza, an inhaled insulin, is gaining praise from patients, if not from ...

High-strength insulin products such as insulin glargine 300 units/ml (Toujeo) have been developed for people with type 1 or type 2 diabetes who have large daily insulin requirements to reduce the ...

Sanofi has launched its new insulin treatment Toujeo in the UK, and says it will be priced at the same level as its big seller Lantus. The pricing decision matches Sanofi's approach in the US market, ...

A longer-acting version of the world's best-selling diabetes drug is now available in the U.K. Sanofi ($SNY) announced the availability of the long-acting basal ...

Toujeo is a long-acting form of insulin. It works by lowering the level of blood sugar in the body. It is not used for diabetic ketoacidosis. Toujeo is given as a subcutaneous injection. For ...